BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 33347952)

  • 21. Clinical characteristics of coronavirus disease 2019 patients complicated with liver injury.
    Wen M; Lu J; Xie Y
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 May; 45(5):555-559. PubMed ID: 32879106
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Liver involvement is not associated with mortality: results from a large cohort of SARS-CoV-2-positive patients.
    Ponziani FR; Del Zompo F; Nesci A; Santopaolo F; Ianiro G; Pompili M; Gasbarrini A;
    Aliment Pharmacol Ther; 2020 Sep; 52(6):1060-1068. PubMed ID: 32628793
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical characteristics and risk factors for liver injury in COVID-19 patients in Wuhan.
    Zhang H; Liao YS; Gong J; Liu J; Zhang H
    World J Gastroenterol; 2020 Aug; 26(31):4694-4702. PubMed ID: 32884226
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Liver injury on admission linked to worse outcomes in COVID-19: an analysis of 14,138 patients.
    Chela HK; Tallon EM; Baskett W; Gangu K; Tahan V; Shyu CR; Daglilar E
    Transl Gastroenterol Hepatol; 2023; 8():4. PubMed ID: 36704655
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sources and clinical significance of aspartate aminotransferase increases in COVID-19.
    Aloisio E; Colombo G; Arrigo C; Dolci A; Panteghini M
    Clin Chim Acta; 2021 Nov; 522():88-95. PubMed ID: 34411557
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatic Predictors of Mortality in Severe Acute Respiratory Syndrome Coronavirus 2: Role of Initial Aspartate Aminotransferase/Alanine Aminotransferase and Preexisting Cirrhosis.
    Frager SZ; Szymanski J; Schwartz JM; Massoumi HS; Kinkhabwala M; Wolkoff AW
    Hepatol Commun; 2021 Mar; 5(3):424-433. PubMed ID: 33681677
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Impact of Liver Chemistries on Respiratory Failure among Hemodialysis Patients with COVID-19 during the Omicron Wave.
    Hori M; Yasuda K; Takahashi H; Aoi T; Mori Y; Tsujita M; Shirasawa Y; Kondo C; Hashimoto T; Koyama H; Morozumi K; Maruyama S
    Intern Med; 2023 Sep; 62(18):2617-2625. PubMed ID: 37407459
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Liver damage at admission is an independent prognostic factor for COVID-19.
    Chen LY; Chu HK; Bai T; Tu SJ; Wei Y; Li ZL; Hu LL; Zhu R; Zhang L; Han CQ; Xiao L; He Q; Song J; Liu WH; Zhu QJ; Chen H; Yang L; Hou XH
    J Dig Dis; 2020 Sep; 21(9):512-518. PubMed ID: 32713118
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SARS-CoV-2 infection of the liver directly contributes to hepatic impairment in patients with COVID-19.
    Wang Y; Liu S; Liu H; Li W; Lin F; Jiang L; Li X; Xu P; Zhang L; Zhao L; Cao Y; Kang J; Yang J; Li L; Liu X; Li Y; Nie R; Mu J; Lu F; Zhao S; Lu J; Zhao J
    J Hepatol; 2020 Oct; 73(4):807-816. PubMed ID: 32437830
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Elevated serum aspartate aminotransferase level identifies patients with coronavirus disease 2019 and predicts the length of hospital stay.
    Gu X; Li X; An X; Yang S; Wu S; Yang X; Wang H
    J Clin Lab Anal; 2020 Jul; 34(7):e23391. PubMed ID: 32488888
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatocellular injury and the mortality risk among patients with COVID-19: A retrospective cohort study.
    Madian A; Eliwa A; Abdalla H; Aly HAA
    World J Hepatol; 2021 Aug; 13(8):939-948. PubMed ID: 34552700
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ACG Clinical Guideline: Evaluation of Abnormal Liver Chemistries.
    Kwo PY; Cohen SM; Lim JK
    Am J Gastroenterol; 2017 Jan; 112(1):18-35. PubMed ID: 27995906
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development and validation of a prognostic nomogram for predicting in-hospital mortality of COVID-19: a multicenter retrospective cohort study of 4086 cases in China.
    Li L; Fang X; Cheng L; Wang P; Li S; Yu H; Zhang Y; Jiang N; Zeng T; Hou C; Zhou J; Li S; Pan Y; Li Y; Nie L; Li Y; Sun Q; Jia H; Li M; Cao G; Ma X
    Aging (Albany NY); 2021 Feb; 13(3):3176-3189. PubMed ID: 33561834
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pattern of liver function and clinical profile in COVID-19: A cross-sectional study of 91 patients.
    Kumar A; Kumar P; Dungdung A; Kumar Gupta A; Anurag A; Kumar A
    Diabetes Metab Syndr; 2020; 14(6):1951-1954. PubMed ID: 33039937
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cryoprotective therapy for huge hepatocellular carcinoma: a study of 14 patients with a single lesion.
    Alnaggar M; Niu L; Li J; Yao F; Wang Y; Zeng J; Ye J; Chen J; Mu F; Xu K
    Cryobiology; 2014 Dec; 69(3):457-61. PubMed ID: 25445461
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Liver injury is independently associated with adverse clinical outcomes in patients with COVID-19.
    Yip TC; Lui GC; Wong VW; Chow VC; Ho TH; Li TC; Tse YK; Hui DS; Chan HL; Wong GL
    Gut; 2021 Apr; 70(4):733-742. PubMed ID: 32641471
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Severity of liver test abnormalities in coronavirus disease 2019 depends on comorbidities and predicts early in-hospital mortality.
    Satapathy SK; Kuntzen C; Qiu H; Jiang Y; Bodenheimer HC; Roth NC; Lee TP; Hirsch JS; Trindade AJ; Bernstein DE;
    Eur J Gastroenterol Hepatol; 2021 Dec; 33(1S Suppl 1):e320-e328. PubMed ID: 33560687
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased Morbidity and Mortality in COVID-19 Patients with Liver Injury.
    Siddiqui MA; Suresh S; Simmer S; Abu-Ghanimeh M; Karrick M; Nimri F; Musleh M; Mediratta V; Al-Shammari M; Russell S; Jou J; Dang D; Salgia R; Zuchelli T
    Dig Dis Sci; 2022 Jun; 67(6):2577-2583. PubMed ID: 33945064
    [TBL] [Abstract][Full Text] [Related]  

  • 40. COVID-19: Abnormal liver function tests.
    Cai Q; Huang D; Yu H; Zhu Z; Xia Z; Su Y; Li Z; Zhou G; Gou J; Qu J; Sun Y; Liu Y; He Q; Chen J; Liu L; Xu L
    J Hepatol; 2020 Sep; 73(3):566-574. PubMed ID: 32298767
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.